ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Oklahoma » Neurology

Top Neurology Prescribers in Oklahoma

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
GREGORY CONNOR M.D.

Neurology

9,028

$1.29M

484
193 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 3%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

19%
prescriptions for brand name drugs

Avg: 24%

$143
Average prescription price

Avg: $242

WALTER LAJARA-NANSON MD

Neurology

5,525

$1.17M

517
401 are 65+

2%
patients receiving schedule two controlled substances

Avg: 2%

2%
patients receiving schedule three controlled substances

Avg: 3%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

29%
prescriptions for brand name drugs

Avg: 24%

$212
Average prescription price

Avg: $242

BAHA ABU-ESHEH MD

Neurology

4,749

$1.03M

468
266 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 3%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

30%
prescriptions for brand name drugs

Avg: 24%

$218
Average prescription price

Avg: $242

JEANNE ANN KING M.D.

Neurology

4,307

$328K

209
29 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

14%
prescriptions for brand name drugs

Avg: 24%

$76
Average prescription price

Avg: $242

JOSEPH KNAPIK MD

Neurology

4,200

$475K

469
368 are 65+

3%
patients receiving schedule two controlled substances

Avg: 2%

12%
patients receiving schedule three controlled substances

Avg: 3%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

19%
prescriptions for brand name drugs

Avg: 24%

$113
Average prescription price

Avg: $242

ELLEN HOPE M.D.

Neurology

3,865

$565K

139
68 are 65+

50%
patients receiving schedule two controlled substances

Avg: 2%

33%
patients receiving schedule three controlled substances

Avg: 3%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

21%
prescriptions for brand name drugs

Avg: 24%

$146
Average prescription price

Avg: $242

TRAVIS KANALY M.D.

Neurology

3,560

$394K

407
289 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

4%
patients receiving schedule three controlled substances

Avg: 3%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

26%
prescriptions for brand name drugs

Avg: 24%

$111
Average prescription price

Avg: $242

WAYNE WASEMILLER MD

Neurology

2,996

$1.07M

322
242 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 3%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

34%
prescriptions for brand name drugs

Avg: 24%

$358
Average prescription price

Avg: $242

ROLFE REITZ MD

Neurology

2,986

$403K

385
321 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 3%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

16%
prescriptions for brand name drugs

Avg: 24%

$135
Average prescription price

Avg: $242

JOHN BANOWETZ MD

Neurology

2,906

$607K

320
247 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 3%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

27%
prescriptions for brand name drugs

Avg: 24%

$209
Average prescription price

Avg: $242

CHARLES MORGAN MD

Neurology

2,815

$520K

432
345 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 3%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

29%
prescriptions for brand name drugs

Avg: 24%

$185
Average prescription price

Avg: $242

MICHAEL TRIBBEY MD

Neurology

2,778

$513K

328
256 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

23%
prescriptions for brand name drugs

Avg: 24%

$185
Average prescription price

Avg: $242

ROBERT DOW M.D.

Neurology

2,772

$699K

294
203 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

6%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

24%
prescriptions for brand name drugs

Avg: 24%

$252
Average prescription price

Avg: $242

SHRIKRISHNA VAIDYA MD

Neurology

2,749

$523K

317
265 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

8%
patients receiving schedule three controlled substances

Avg: 3%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

19%
prescriptions for brand name drugs

Avg: 24%

$190
Average prescription price

Avg: $242

DESIREE ORTIZ-CRUZ MD JD

Neurology

2,589

$501K

178
112 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 3%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

36%
prescriptions for brand name drugs

Avg: 24%

$193
Average prescription price

Avg: $242

ALOK PASRICHA M.D.

Neurology

2,566

$1.07M

357
232 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

8%
patients receiving schedule three controlled substances

Avg: 3%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

34%
prescriptions for brand name drugs

Avg: 24%

$418
Average prescription price

Avg: $242

KEVIN WOOD MD

Neurology

2,382

$523K

290
222 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

5%
patients receiving schedule three controlled substances

Avg: 3%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

19%
prescriptions for brand name drugs

Avg: 24%

$220
Average prescription price

Avg: $242

TIMOTHY OWNBEY D.O.

Neurology

2,336

$385K

325
233 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 3%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

14%
prescriptions for brand name drugs

Avg: 24%

$165
Average prescription price

Avg: $242

CHARLES LUTTON M.D.

Neurology

2,285

$763K

238
153 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

32%
prescriptions for brand name drugs

Avg: 24%

$334
Average prescription price

Avg: $242

RODNEY MYERS MD

Neurology

2,261

$600K

304
193 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

21%
prescriptions for brand name drugs

Avg: 24%

$265
Average prescription price

Avg: $242

LUIS REINA MD

Neurology

2,147

$476K

214
126 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

31%
prescriptions for brand name drugs

Avg: 24%

$222
Average prescription price

Avg: $242

ZAHID CHEEMA MD

Neurology

2,142

$1.22M

235
123 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

6%
patients receiving schedule three controlled substances

Avg: 3%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

26%
prescriptions for brand name drugs

Avg: 24%

$569
Average prescription price

Avg: $242

JORGE GONZALEZ MD

Neurology

1,977

$384K

234
123 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 3%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

32%
prescriptions for brand name drugs

Avg: 24%

$194
Average prescription price

Avg: $242

TODD DUNAWAY MD

Neurology

1,809

$951K

253
193 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

34%
prescriptions for brand name drugs

Avg: 24%

$526
Average prescription price

Avg: $242

MATTHEW RYAN MD

Neurology

1,808

$407K

226
153 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

22%
prescriptions for brand name drugs

Avg: 24%

$225
Average prescription price

Avg: $242

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank